How big is the urinary tract infection testing market?

The global urinary tract infection testing market size was valued at USD 579.2 million in 2022 and is anticipated to reach USD 602.7 million in 2023.

What is the urinary tract infection testing market growth?

The global urinary tract infection testing market is expected to witness a compound annual growth rate of 4.4% from 2023 to 2030 to reach USD 812.0 million by 2030.

Which segment accounted for the largest urinary tract infection testing market share?

Based on type, the cystitis segment accounted for a share of 41.42% in 2022 due to the high incidence & recurrence rate of cystitis and the increasing number of diabetes patients who are more prone to cystitis.

Who are the key players in the urinary tract infection testing market?

Some of the key players in the UTI testing market are QIAGEN; Accelerate Diagnostics, Inc.; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche Ltd.; Danaher Corporation; Siemens Healthcare GmbH; Randox Laboratories Ltd.; Thermo Fisher Scientific, Inc.; bioMérieux SA; T2 Biosystems, Inc.

What are the factors driving the urinary tract infection testing market?

The major factors driving UTI testing market growth are the rising disease burden and the launch of at-home and self-testing kits for the early diagnosis of UTI.